Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 4—April 2025
Research Letter
Genomic Characterization of Yersinia enterocolitica Isolates, Costa Rica
Cyril Savin
, Gletty Oropeza, Luis A. Barboza Fallas, Olga Rivas-Solano, Grettel Chanto, and Javier Pizarro-Cerdá
, Gletty Oropeza, Luis A. Barboza Fallas, Olga Rivas-Solano, Grettel Chanto, and Javier Pizarro-Cerdá
Table
Epidemiologic characteristics of cgMLST clusters of Yersinia enterocolitica isolates, Costa Rica*
| cgMLST cluster | No. isolates from Costa Rica | No. isolates in cluster | Category | Country | Isolation dates |
|---|---|---|---|---|---|
| 6122 | 27 | 27 | Clinical | Costa Rica | 2004–2014 |
| 6127 | 8 | 8 | Clinical | Costa Rica | 2006–2019 |
| 6180 | 3 | 3 | Clinical | Costa Rica | 2014–2016 |
| 3151 | 3 | 3 | Clinical, veterinary | Costa Rica | 2018–2022 |
| 6124 | 2 | 2 | Clinical | Costa Rica | 2005–2013 |
| 6149 | 2 | 2 | Clinical | Costa Rica | 2007–2008 |
| 6164 | 2 | 2 | Clinical | Costa Rica | 2008–2011 |
| 6212 | 2 | 2 | Clinical | Costa Rica | 2012–2015 |
| 5652 | 2 | 3 | Clinical | Costa Rica and France | 2015–2023 |
*Clinical isolates are from human samples. cgMLST, core genome multilocus sequence typing.
Page created: February 28, 2025
Page updated: March 12, 2025
Page reviewed: March 12, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.